Catalyst overview
Research summary
This catalyst tracks a Phase 2b data readout for Miricorilant in Non-alcoholic steatohepatitis . The expected timing is based on the latest available company guidance and may change.
07/29/26:- MONARCH Phase 2b MASH results remain expected by Q4 2026.
Verification
Confirm timing and program details against the company announcement or filing.